Literature DB >> 17574270

Serotonin-1A autoreceptor binding in the dorsal raphe nucleus of depressed suicides.

Maura Boldrini1, Mark D Underwood, J John Mann, Victoria Arango.   

Abstract

Serotonergic dysfunction is present in mood disorders and suicide. Brainstem 5-HT1A somatodendritic autoreceptors regulate serotonin neuron firing but studies of autoreceptor binding in the dorsal raphe nucleus (DRN) in depressed suicides report conflicting results. We sought to determine: (1) the anatomical distribution of 5-HT1A receptor binding in the DRN in depressed suicides and psychiatrically normal controls; and (2) whether sex differences in 5-HT1A binding in the DRN contribute to differences between depressed suicides and controls. Previously collected quantitative receptor autoradiograms of [3H]8-hydroxy-2-(di-n-propyl)aminotetralin (3H-8-OH-DPAT) in postmortem tissue sections containing the DRN from drug-free suicide victims (n=10) and matched controls (n=10) were analyzed. Less total receptor binding (fmol/mg tissuexmm3) was observed in the entire DRN in depressed suicides compared with controls (p<0.05). Group differences along the rostrocaudal extent of the DRN were observed for cross-sectional 5-HT(1A) binding (fmol/mg tissue) and receptor binding (fmol/mgxmm3, p<0.05). Cross-sectional 5-HT1A DRN binding in depressed suicides compared with controls was higher rostrally and lower caudally. The differences between depressed suicides and controls were present in males and females, although females had more binding than males. Less autoreceptor binding in the DRN of depressed suicides may represent a homeostatic response to less serotonin release, increasing serotonin neuron firing. More autoreceptor binding in rostral DRN might contribute to deficient serotonin release in ventromedial prefrontal cortex by lower neuronal firing.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17574270      PMCID: PMC2268626          DOI: 10.1016/j.jpsychires.2007.05.004

Source DB:  PubMed          Journal:  J Psychiatr Res        ISSN: 0022-3956            Impact factor:   4.791


  51 in total

1.  Normal levels of tryptophan hydroxylase immunoreactivity in the dorsal raphe of depressed suicide victims.

Authors:  Willy L Bonkale; Shayna Murdock; Janine E Janosky; Mark C Austin
Journal:  J Neurochem       Date:  2004-02       Impact factor: 5.372

2.  The morphology and divergent axonal organization of midbrain raphe projection neurons in the rat.

Authors:  H Imai; M R Park; D A Steindler; S T Kitai
Journal:  Brain Dev       Date:  1986       Impact factor: 1.961

3.  Serotonin 1A receptors, serotonin transporter binding and serotonin transporter mRNA expression in the brainstem of depressed suicide victims.

Authors:  V Arango; M D Underwood; M Boldrini; H Tamir; S A Kassir; S Hsiung; J J Chen; J J Mann
Journal:  Neuropsychopharmacology       Date:  2001-12       Impact factor: 7.853

4.  Antidromically identified serotonergic neurons in the rat midbrain raphe: evidence for collateral inhibition.

Authors:  R Y Wang; G K Aghajanian
Journal:  Brain Res       Date:  1977-08-19       Impact factor: 3.252

5.  Presynaptic 5-HT autoreceptors on serotonergic cell bodies and/or dendrites but not terminals are of the 5-HT1A subtype.

Authors:  D Verge; G Daval; A Patey; H Gozlan; S el Mestikawy; M Hamon
Journal:  Eur J Pharmacol       Date:  1985-07-31       Impact factor: 4.432

6.  8-Hydroxy-2-(di-n-propylamino)-tetralin discriminates between subtypes of the 5-HT1 recognition site.

Authors:  D N Middlemiss; J R Fozard
Journal:  Eur J Pharmacol       Date:  1983-05-20       Impact factor: 4.432

Review 7.  Electrophysiologically-identified serotonin receptors in the rat CNS. Effect of antidepressant treatment.

Authors:  C de Montigny; P Blier; Y Chaput
Journal:  Neuropharmacology       Date:  1984-12       Impact factor: 5.250

8.  Serotonin receptor modulation by estrogen in discrete brain nuclei.

Authors:  A Biegon; C T Fischette; T C Rainbow; B S McEwen
Journal:  Neuroendocrinology       Date:  1982-10       Impact factor: 4.914

9.  Acute treatment with the antidepressant fluoxetine internalizes 5-HT1A autoreceptors and reduces the in vivo binding of the PET radioligand [18F]MPPF in the nucleus raphe dorsalis of rat.

Authors:  Mustapha Riad; Luc Zimmer; Latifa Rbah; Kenneth C Watkins; Michel Hamon; Laurent Descarries
Journal:  J Neurosci       Date:  2004-06-09       Impact factor: 6.167

Review 10.  Regulation of 5-HT1A receptor function in brain following agonist or antidepressant administration.

Authors:  Julie G Hensler
Journal:  Life Sci       Date:  2003-02-28       Impact factor: 5.037

View more
  63 in total

1.  Comorbidity between epilepsy and depression: experimental evidence for the involvement of serotonergic, glucocorticoid, and neuroinflammatory mechanisms.

Authors:  Eduardo Pineda; Don Shin; Raman Sankar; Andrey M Mazarati
Journal:  Epilepsia       Date:  2010-07       Impact factor: 5.864

2.  Length of axons expressing the serotonin transporter in orbitofrontal cortex is lower with age in depression.

Authors:  Grazyna Rajkowska; Gouri Mahajan; Beata Legutko; Lavanya Challagundla; Michael Griswold; Paul R Albert; Mireille Daigle; Jose J Miguel-Hidalgo; Mark C Austin; Randy D Blakely; David C Steffens; Craig A Stockmeier
Journal:  Neuroscience       Date:  2017-07-13       Impact factor: 3.590

Review 3.  5-HT(1A) receptor function in major depressive disorder.

Authors:  Jonathan Savitz; Irwin Lucki; Wayne C Drevets
Journal:  Prog Neurobiol       Date:  2009-02-07       Impact factor: 11.685

Review 4.  Toward a biosignature for suicide.

Authors:  Maria A Oquendo; Gregory M Sullivan; Katherin Sudol; Enrique Baca-Garcia; Barbara H Stanley; M Elizabeth Sublette; J John Mann
Journal:  Am J Psychiatry       Date:  2014-10-31       Impact factor: 18.112

Review 5.  Serotonin 1A and Serotonin 4 Receptors: Essential Mediators of the Neurogenic and Behavioral Actions of Antidepressants.

Authors:  Benjamin Adam Samuels; Indira Mendez-David; Charlène Faye; Sylvain André David; Kerri A Pierz; Alain M Gardier; René Hen; Denis J David
Journal:  Neuroscientist       Date:  2014-12-08       Impact factor: 7.519

6.  Gender-specific decrease in NUDR and 5-HT1A receptor proteins in the prefrontal cortex of subjects with major depressive disorder.

Authors:  Bernadeta Szewczyk; Paul R Albert; Ariel M Burns; Margaret Czesak; James C Overholser; George J Jurjus; Herbert Y Meltzer; Lisa C Konick; Lesa Dieter; Nicole Herbst; Warren May; Grazyna Rajkowska; Craig A Stockmeier; Mark C Austin
Journal:  Int J Neuropsychopharmacol       Date:  2008-06-19       Impact factor: 5.176

7.  Autoradiographic evaluation of [3H]CUMI-101, a novel, selective 5-HT1AR ligand in human and baboon brain.

Authors:  J S Dileep Kumar; Ramin V Parsey; Suham A Kassir; Vattoly J Majo; Matthew S Milak; Jaya Prabhakaran; Norman R Simpson; Mark D Underwood; J John Mann; Victoria Arango
Journal:  Brain Res       Date:  2013-02-27       Impact factor: 3.252

8.  Comorbidity between epilepsy and depression: role of hippocampal interleukin-1beta.

Authors:  Andrey M Mazarati; Eduardo Pineda; Don Shin; Delia Tio; Anna N Taylor; Raman Sankar
Journal:  Neurobiol Dis       Date:  2009-11-10       Impact factor: 5.996

9.  Modifying 5-HT1A Receptor Gene Expression as a New Target for Antidepressant Therapy.

Authors:  Paul R Albert; Brice Le François
Journal:  Front Neurosci       Date:  2010-06-17       Impact factor: 4.677

10.  Elevated serotonin 1A binding in remitted major depressive disorder: evidence for a trait biological abnormality.

Authors:  Jeffrey M Miller; Kathleen G Brennan; Todd R Ogden; Maria A Oquendo; Gregory M Sullivan; J John Mann; Ramin V Parsey
Journal:  Neuropsychopharmacology       Date:  2009-05-20       Impact factor: 7.853

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.